Yiu Wa Alec Tsui

Independent Non-Executive Director at Brii Biosciences

Mr. Yiu Wa Alec Tsui has over 40 years of experience in finance and administration, corporate and strategic planning, information technology, and human resources management.

Mr. Tsui has been an independent non-executive director of a number of companies listed on the Stock Exchange, namely, COSCO Shipping International (Hong Kong) Co., Ltd. (stock code: 517) since February 2004, Pacific Online Limited (stock code: 543) since November 2007 and Hua Medicine (stock code: 2552) since September 2018. He has also been serving as the independent director of a number of companies listed on the NASDAQ Stock Exchange in the United States, namely, ATA Creativity Global (stock code: AACG) since January 2008 and Melco Resorts & Entertainment Limited (stock code: MLCO) since December 2006. Since August 2000, he has also been an independent non-executive director of Industrial & Commercial Bank of China (Asia) Limited (stock code: 349) and was delisted with effect from December 21, 2010. In addition, Mr. Tsui has been serving as a director to WAG Worldsec Management Consultancy Limited, a consulting company, and he is responsible for setting the strategic direction of the company and the day-to-day management of the company since April 2006. Mr. Tsui also served as independent non-executive directors in various other Hong Kong-listed companies previously.

Mr. Tsui was admitted as a member of the Hong Kong Securities and Investment Institute in November 1998 and became the senior fellow of the Hong Kong Securities and Investment Institute in September 2014.

Mr. Tsui obtained his Bachelor of Science in Industrial Engineering from the University of Tennessee in the United States in June 1975 and a Master of Engineering from the University of Tennessee in the United States in August 1976. He also completed the Program for Senior Managers in Government at the John F. Kennedy School of Government at Harvard University in the United States in August 1993.